Wuhan Ruijian Pharmaceutical Technology

Developer of cell therapies to treat neurological and ophthalmological diseases

placeWuhan, Hubei, China calendar_todayFounded 2017 language iregene.com

Social engagement

Social engagement: 409 social following, 4 posts in the last 12 months — below the industry typical range.

Investor mix

3 investors on record; lead investors include Fortune Capital, NLVC.

Investor typeCountShare
Venture capital267%
Bank & private debt133%

Recent activity

27 Feb 2026
Milestone
regulatory
28 Jan 2026
Milestone
regulatory
Coming soon